Atara Biotherapeutics (ATRA) Exchange Rate Effect (2016)
Atara Biotherapeutics (ATRA) reported Exchange Rate Effect of $38000.0 for Q2 2016, up 190.48% quarter-over-quarter from -$42000.0 in Q1 2016.
Atara Biotherapeutics (ATRA) Exchange Rate Effect (2016) Analysis & Trends
Atara Biotherapeutics has reported Exchange Rate Effect for 1 years, with the latest figure at $38000.0 in Q2 2016.
- For the quarter ending Q2 2016, Exchange Rate Effect changed N/A year-over-year to $38000.0; the trailing twelve-month figure through Jun 2017 stood at -$4000.0 (changed N/A YoY), and the FY2015 full-year result was -$94000.0, changed N/A from the prior year.
- Exchange Rate Effect for Q2 2016 stood at $38000.0, up from -$42000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $38000.0 in Q2 2016, with the low at -$42000.0 in Q1 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 8.68 Mn |
| 10 | Atara Biotherapeutics | 134.61 Mn | 126.21 Mn | 392,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 38,000.00 |
| Jun 30, 2016 | 38,000.00 |
| Mar 31, 2016 | -42,000.00 |
| Mar 31, 2016 | -42,000.00 |